CHE

NEUTRALEarnings

Chemed Corp

2026-08-10

Price

$549.48

-0.59%

This is the 2026-08-10 snapshot — the signals and analysis for CHE as of this single trading day.

View full CHE research hub →

Score8.5Priority

Signals4/8 DNA0/13 Act · 1/4 Risk

SentimentNEUTRALScore: 8

Volume0.7xvs 20d avg

Analysis

Chemed (CHE) is exhibiting High-Conviction Price Discovery, driven by a recent Q2 earnings beat, raised FY2026 guidance, and an August 6th dividend hike. Technical signals including ALPHA_MALE and PERFECT_STACK confirm strong institutional accumulation as the stock pushes 52-week highs, blowing past cautious Wall Street price targets. Supported by a robust RISK_ON macro regime with muted volatility, investors are confidently rewarding CHE's VITAS outperformance and capital return narrative, further fueled by underlying activist pressure for a strategic review.

Fired Signals

ALPHA MALESTEADY CLIMBGOLDEN CROSSPERFECT STACKWEAK FINISH

Key Takeaways

Actionable Thesis: Ride the High-Conviction Price Discovery as CHE's PERFECT_STACK and ALPHA_MALE signals align with a strong fundamental re-rating from Q2 earnings and a dividend hike.
Key Risk: The stock is trading at a premium to average analyst price targets (e.g., BofA's $510), which could invite valuation-driven profit-taking.
What to Watch: Maintain a strict trailing stop around the $491.89 line-in-the-sand to protect gains while monitoring for any strategic updates from activist investor Barington.

← Back to 2026-08-10 View Full CHE History →Yahoo Finance &nearr;